Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

4G Vaccines

M&A STATUS
M&A LATEST DEAL TYPE
1 INVESTORS
Description

Developer of vaccines products. The company's vaccines focus on treatment of oncology and infectious diseases, enabling the medical industry to treat their patients in proper and better manner.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • Kronheimer Building
  • Heidelberg, Victoria 3084
  • Australia
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore 4G Vaccines’s full profile, request a free trial.

4G Vaccines Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jan-2012 Completed Generating Revenue
4. Merger/Acquisition 15-Jun-2012 Cancelled Generating Revenue
3. Grant 01-Jan-2009 0000 Completed Generating Revenue
2. Grant 01-Jan-2008 $372K Completed Generating Revenue
1. Early Stage VC 01-Nov-2006 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

4G Vaccines Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
SciVentures Investments Venture Capital Minority 000 0000 000000 0